Characterizing a thermostable Cas9 for bacterial genome editing and silencing I Mougiakos, P Mohanraju, EF Bosma, V Vrouwe, M Finger-Bou, ... Nature communications 8 (1), 1-11, 2017 | 146 | 2017 |
Replacing the Calvin cycle with the reductive glycine pathway in Cupriavidus necator NJ Claassens, G Bordanaba-Florit, CAR Cotton, A De Maria, ... Metabolic Engineering 62, 30-41, 2020 | 111 | 2020 |
The ongoing quest to crack the genetic code for protein production T Nieuwkoop, M Finger-Bou, J van der Oost, NJ Claassens Molecular cell 80 (2), 193-209, 2020 | 39 | 2020 |
Bicistronic Design-Based Continuous and High-Level Membrane Protein Production in Escherichia coli NJ Claassens, M Finger-Bou, B Scholten, F Muis, JJ De Groot, JW de Gier, ... ACS synthetic biology 8 (7), 1685-1690, 2019 | 25 | 2019 |
CRISPR with a Happy Ending: Non‐Templated DNA Repair for Prokaryotic Genome Engineering M Finger‐Bou, E Orsi, J van der Oost, RHJ Staals Biotechnology Journal, 1900404, 2020 | 15 | 2020 |
Not So Giant Steps On Tuning Protein Production And Diminished Genomes M Finger-Bou Wageningen University, 2023 | | 2023 |
Towards a formate bio-economy: establishing the reductive glycine pathway O Yishai, N Claassens, MF Bou, J Verbunt, G Scarinci, A Bar-Even | | 2018 |
Towards a sustainable, efficient formate bio-economy: replacing the Calvin cycle by a highly efficient synthetic pathway in a formatotroph NJ Claassens, G Bordanaba-Florit, M Finger-Bou, CAR Cotton, ... | | |